Spectral Diagnostics Income After Taxes 2010-2024 | EDTXF
Spectral Diagnostics income after taxes from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
| Spectral Diagnostics Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2024 | $-11 |
| 2023 | $-11 |
| 2022 | $-6 |
| 2021 | $-7 |
| 2020 | $-7 |
| 2019 | $-4 |
| 2018 | $-2 |
| 2017 | $-3 |
| 2016 | $-8 |
| 2015 | $-7 |
| 2014 | $-9 |
| 2013 | $-11 |
| 2012 | $-9 |
| 2011 | $-7 |
| 2010 | $-6 |
| 2009 | $-2 |
| Spectral Diagnostics Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2024-12-31 | $2 |
| 2024-09-30 | $-7 |
| 2024-06-30 | $-3 |
| 2024-03-31 | $-3 |
| 2023-12-31 | $-5 |
| 2023-09-30 | $-2 |
| 2023-06-30 | $-3 |
| 2023-03-31 | $-1 |
| 2022-12-31 | $1 |
| 2022-09-30 | $-2 |
| 2022-06-30 | $-2 |
| 2022-03-31 | $-2 |
| 2021-12-31 | $-2 |
| 2021-09-30 | $-2 |
| 2021-06-30 | $-2 |
| 2021-03-31 | $-1 |
| 2020-12-31 | $756 |
| 2020-09-30 | $-1 |
| 2020-06-30 | $-759 |
| 2020-03-31 | $-3 |
| 2019-12-31 | $-1 |
| 2019-09-30 | $-1 |
| 2019-06-30 | $-1 |
| 2019-03-31 | $-1 |
| 2018-12-31 | $0 |
| 2018-09-30 | $-1 |
| 2018-06-30 | $-1 |
| 2018-03-31 | $-1 |
| 2017-12-31 | $-1 |
| 2017-09-30 | $-1 |
| 2017-06-30 | $-1 |
| 2017-03-31 | $-1 |
| 2016-12-31 | $-1 |
| 2016-09-30 | $-2 |
| 2016-06-30 | $-3 |
| 2016-03-31 | $-2 |
| 2015-12-31 | $-2 |
| 2015-09-30 | $-2 |
| 2015-06-30 | $-2 |
| 2015-03-31 | $-2 |
| 2014-12-31 | $-2 |
| 2014-09-30 | $-2 |
| 2014-06-30 | $-2 |
| 2014-03-31 | $-3 |
| 2013-12-31 | $-4 |
| 2013-09-30 | $-2 |
| 2013-06-30 | $-3 |
| 2013-03-31 | $-2 |
| 2012-12-31 | $-2 |
| 2012-09-30 | $-2 |
| 2012-06-30 | $-2 |
| 2012-03-31 | $-2 |
| 2011-12-31 | $-2 |
| 2011-09-30 | $-2 |
| 2011-06-30 | $-2 |
| 2011-03-31 | $-1 |
| 2010-12-31 | $-2 |
| 2010-09-30 | $-1 |
| 2010-06-30 | $-1 |
| 2010-03-31 | $-2 |
| 2009-12-31 | $-1 |
| 2009-09-30 | $0 |
| 2009-06-30 | $-1 |
| 2009-03-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.168B | $0.002B |
| Spectral Medical Inc. develops and commercializes theranostic treatment for severe sepsis. The company's products include Endotoxin Activity Assay, a rapid diagnostic test for detection of components of gram negative bacterial cell wall; and Toraymyxin, a therapeutic hemoperfusion device for the treatment of sepsis that removes endotoxin from the bloodstream. Spectral Medical Inc., formerly known as Spectral Diagnostics Inc., is headquartered in Toronto, Canada. | |||